Oncology Institute Schedules Shareholder Vote
Ticker: TOIIW · Form: 8-K · Filed: Jun 13, 2024 · CIK: 1799191
| Field | Detail |
|---|---|
| Company | Oncology Institute, Inc. (TOIIW) |
| Form Type | 8-K |
| Filed Date | Jun 13, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
TL;DR
TOI is holding a shareholder vote soon, get ready to cast your ballot.
AI Summary
On June 13, 2024, The Oncology Institute, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. This filing indicates that important decisions regarding the company's future will be put before its shareholders for approval.
Why It Matters
Shareholder votes are critical for corporate governance, as they allow investors to influence major company decisions and the direction of the business.
Risk Assessment
Risk Level: low — This filing is procedural and reports on an upcoming shareholder vote, not a material event like a merger or financial distress.
Key Players & Entities
- The Oncology Institute, Inc. (company) — Registrant
- DFP HEALTHCARE ACQUISITIONS CORP. (company) — Former Company Name
- June 13, 2024 (date) — Date of Report
FAQ
What specific matters will be submitted for a vote by The Oncology Institute, Inc.'s security holders?
The filing states that matters will be submitted to a vote of security holders, but does not specify the exact proposals in this current report.
When was this 8-K report filed?
This 8-K report was filed on June 13, 2024.
What is the exact name of the registrant?
The exact name of the registrant is The Oncology Institute, Inc.
What was the former name of The Oncology Institute, Inc.?
The former name of The Oncology Institute, Inc. was DFP HEALTHCARE ACQUISITIONS CORP.
In which jurisdiction was The Oncology Institute, Inc. incorporated?
The Oncology Institute, Inc. was incorporated in Delaware.
Filing Stats: 806 words · 3 min read · ~3 pages · Grade level 13 · Accepted 2024-06-13 17:07:29
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 TOI The Nasdaq Stock Market LLC R
- $11.50 — mon Stock, each at an exercise price of $11.50 per share TOIIW The Nasdaq Stock Ma
Filing Documents
- toi_8k-agm.htm (8-K) — 39KB
- 0001079973-24-000876.txt ( ) — 256KB
- toi-20240613.xsd (EX-101.SCH) — 4KB
- toi-20240613_def.xml (EX-101.DEF) — 26KB
- toi-20240613_lab.xml (EX-101.LAB) — 36KB
- toi-20240613_pre.xml (EX-101.PRE) — 25KB
- toi_8k-agm_htm.xml (XML) — 6KB
07 Submission
Item 5.07 Submission of Matters to a Vote of Security Holders. On June 13, 2024, The Oncology Institute, Inc. (the "Company") held its 2024 Annual Meeting Stockholders (the "2024 Annual Meeting") in which the Company's stockholders considered three proposals, each of which is described in more detail in the Company's Definitive Proxy Statement, filed with the U.S. Securities and Exchange Commission (the "SEC") on May 2, 2024. At the meeting, a total of 61,082,992 shares of the Company's common stock, par value $0.0001 per share ("Common Stock") were voted, representing 82.06% of the 74,435,707 shares of Common Stock outstanding as of the April 15, 2024 record date. The results of the items voted on at the 2024 Annual Meeting are as follows: Proposal 1: Election of Directors The Company's stockholders elected nine directors to serve for the ensuing year and until their successors are elected and qualified, or until their earlier death, resignation or removal. The Company elects its directors on a plurality vote basis. The votes regarding the election of directors were as follows: Nominee For Authority Withheld Broker Non-Votes Richard Barasch 48,707,815 173,921 12,201,256 Maeve O'Meara Duke 48,846,098 38,231 12.198,663 Brad Hively 47,659,187 1,222,549 12,201,256 Karen Johnson 46,859,208 2,023,214 12,200,570 Mohit Kaushal 48,014,989 867,433 12,200,570 Gabriel Ling 48,709,376 172,360 12,201,256 Anne McGeorge 48,019,855 862,567 12,200,570 Mark Pacala 47,995,874 886,548 12,200,570 Daniel Virnich 48,828,032 56,297 12,198,663 Proposal 2: Ratification of the Appointment of Independent Registered Public Accountants The ratification of the appointment of BDO USA, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was approved. The votes regarding the ratification of the appointment were as follows: For Against Abstain Bro